Please provide your email address to receive an email when new articles are posted on . The U.S. Federal Trade Commission voted 3-2 on Feb. 19 to approve the $2 billion merger between Fresenius ...

Fresenius Medical Care is set to buy NxStage Medical for about $2 billion. The takeover will bolster Fresenius’ presence in the at-home dialysis market, positioning it to continue profiting if ...

In light of the Akorn-Fresenius merger fallout, we take a look at the Fresenius-NXTM pending merger. The market has been skeptical about the deal with NXTM's shares currently selling at 12% discount ...

Discover more of our free reports coverage from other companies within the Medical Appliances & Equipment industry. Pro-TD has currently selected Boston Scientific Corporation (NYSE: BSX) for ...

Acquisition of NxStage Medical, Inc. would: - position Fresenius Medical Care as a global leader in home dialysis - establish U.S. presence in the critical care space - further enhance clinical ...

Fresenius SE & Co.'s minority-owned kidney dialysis business agreed Monday to acquire NxStage Medical Inc. for about $2 billion as part of the German health-care provider's broader push into the U.S.

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

While the strategic rationale behind Fresenius Medical Care's $2 billion bid for NxStage Medical is clear, the timing of the deal is vague. Amanda Pedersen As Fresenius Medical Care kicked off a ...

Fresenius Medical Care announced Tuesday it completed the $2 billion acquisition of home dialysis devicemaker NxStage Medical, about a year and a half after the companies first announced the deal. The ...

NxStage, which just like Fresenius Medical Care North America has its headquarters in the Boston, Massachusetts area, was founded in 1998 and has approximately 3,400 employees. It develops, produces ...

Fresenius Medical Care, the world's largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc., (NxStage) (NASDAQ: NXTM) a U.S.-based medical ...